Apoptosis and chemotherapy for bladder cancer

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Bladder transitional cell carcinoma (TCC) often exhibits resistance to chemotherapy.
• Apoptosis, or programmed cell death, plays a critical role in cellular responses to cancer treatments.
• Understanding the mechanisms of apoptosis is crucial for developing effective bladder cancer therapies.

Purpose of the Study:

• To review the role of apoptosis in the chemosensitivity of bladder cancer cells.
• To explore how apoptosis induction influences treatment response in bladder TCC.
• To highlight the importance of apoptosis in overcoming chemoresistance.

Main Methods:

• A targeted MEDLINE literature search was conducted on apoptosis, bladder cancer, and chemotherapy.
• Characteristics and detection methods for apoptotic cells were defined.
• The role of apoptosis mediators in bladder cancer chemosensitivity and disease stage was analyzed.

Main Results:

• Apoptosis is regulated by the balance of pro-apoptotic and anti-apoptotic proteins.
• Alterations in apoptosis-related genes and proteins in bladder cancer promote cell survival and chemoresistance.
• Chemotherapy effectiveness is linked to the induction of apoptosis in cancer cells.

Conclusions:

• Current research aims to restore chemosensitivity in bladder cancer by promoting apoptosis.
• Shifting bladder cancer cells towards a pro-apoptotic phenotype is a key therapeutic strategy.
• Translating these findings into clinical practice could improve survival rates for patients with poor prognoses.